Live Breaking News & Updates on Brazilian Health Regulator

Stay updated with breaking news from Brazilian health regulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19 vaccine: Brazil rejects import of Russia's Sputnik V; cites inherent risks, serious defects


COVID-19 vaccine: Brazil rejects import of Russia s Sputnik V; cites inherent risks, serious defects
Anvisa s five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted inherent risks and serious defects, citing a lack of information guaranteeing its safety, quality and effectiveness
Reuters | April 27, 2021 | Updated 14:33 IST
The Brazilian health regulator Anvisa on Monday rejected importing the Russian-made Sputnik V Covid-19 vaccine requested by state governors battling a deadly second wave of the virus that is battering Latin America s largest nation. Anvisa s five-strong board voted unanimously not to approve the Russian vaccine after technical staff had highlighted inherent risks and serious defects, citing a lack of information guaranteeing its safety, quality and effectiveness. ....

United States , Moreira Marino Araujo , Gustavo Mendes , European Union , Moscow Gamaleya Institute , Russian Direct Investment Fund , Latin America , Carolina Moreira Marino Araujo , Gamaleya Institute , Covid 19 Vaccine , Sputnik V , Sputnikv Covid 19 Vaccine , Covid 19 Vaccine Brazil , Sputnikv Covid 19 Vaccine Brazil , Brazilian Health Regulator , Covid 19 Hotspots , ஒன்றுபட்டது மாநிலங்களில் , குஸ்டாவோ மேஂடெஸ் , ஐரோப்பிய தொழிற்சங்கம் , ரஷ்ய நேரடி முதலீடு நிதி , லத்தீன் அமெரிக்கா , ஸ்பட்நிக் வ் , பிரேசிலியன் ஆரோக்கியம் சீராக்கி ,

Brazilian health regulator Anvisa AstraZeneca China Sinovac Biotech Ltd COVID 19 vaccines Russia Sputnik V


URL copied
Brazil says no to Russia s Sputnik V
The Brazil National Health Surveillance Agency (Anvisa)  declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil. While, emergency use of COVID-19 vaccines from China’s Sinovac Biotech Ltd and Britain’s AstraZeneca have been approved by the regulator. 
Citing the agency, TASS reported that the request does not comply with the minimal criteria for this task.
The request was returned to Uniao Quimica, because it does not comply with the minimal criteria in particular, due to lack of permission for third phase of clinical trials, as well as in regards to issue dealing with the advanced production methods, TASS quoted the Anivsa. ....

Uniao Quimica , Russian Fund , China Sinovac Biotech Ltd , Brazil National Health Surveillance Agency Anvisa , Russian Direct Investment Fund , Image Source , Brazil National Health Surveillance Agency , Sinovac Biotech Ltd , Brazilian Health Regulator , Chinese Vaccine , Covid 19 Vaccines , Sputnik V , Astrazeneca Vaccine , Chinese Covid 19 Vaccine , Chinese Coronavirus Vaccine , Brazil Vaccine , Brazil Coronavirus Vaccine , ஊனியஓ குவிமிகா , ரஷ்ய நிதி , ரஷ்ய நேரடி முதலீடு நிதி , படம் மூல , பிரேசிலியன் ஆரோக்கியம் சீராக்கி , சீன தடுப்பூசி , ஸ்பட்நிக் வ் , பிரேசில் தடுப்பூசி ,